Aussie8 – Lifestyle
Author:
WIRE NEWS NETWORK
Sentynl Therapeutics Enters into Agreement with PRG S&T to License Molecule for Hutchinson-Gilford Progeria Syndrome
March 16, 2026
Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis
March 16, 2026
←
Previous Page
1
2
3